Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="cancer-primary-site-cs"/>
<language value="en"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem cancer-primary-site-cs</b></p><a name="cancer-primary-site-cs"> </a><a name="hccancer-primary-site-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">BREAST<a name="cancer-primary-site-cs-BREAST"> </a></td><td>Breast</td><td>C50 — Malignant neoplasm of breast.</td></tr><tr><td style="white-space:nowrap">CERVIX-UTERI<a name="cancer-primary-site-cs-CERVIX-UTERI"> </a></td><td>Cervix Uteri</td><td>C53 — Malignant neoplasm of cervix uteri.</td></tr><tr><td style="white-space:nowrap">CORPUS-UTERI<a name="cancer-primary-site-cs-CORPUS-UTERI"> </a></td><td>Corpus Uteri</td><td>C54 — Malignant neoplasm of corpus uteri.</td></tr><tr><td style="white-space:nowrap">OVARY<a name="cancer-primary-site-cs-OVARY"> </a></td><td>Ovary</td><td>C56 — Malignant neoplasm of ovary.</td></tr><tr><td style="white-space:nowrap">PROSTATE<a name="cancer-primary-site-cs-PROSTATE"> </a></td><td>Prostate</td><td>C61 — Malignant neoplasm of prostate.</td></tr><tr><td style="white-space:nowrap">COLON<a name="cancer-primary-site-cs-COLON"> </a></td><td>Colon</td><td>C18 — Malignant neoplasm of colon.</td></tr><tr><td style="white-space:nowrap">RECTUM<a name="cancer-primary-site-cs-RECTUM"> </a></td><td>Rectum</td><td>C20 — Malignant neoplasm of rectum.</td></tr><tr><td style="white-space:nowrap">OESOPHAGUS<a name="cancer-primary-site-cs-OESOPHAGUS"> </a></td><td>Oesophagus</td><td>C15 — Malignant neoplasm of oesophagus.</td></tr><tr><td style="white-space:nowrap">STOMACH<a name="cancer-primary-site-cs-STOMACH"> </a></td><td>Stomach</td><td>C16 — Malignant neoplasm of stomach.</td></tr><tr><td style="white-space:nowrap">LIVER<a name="cancer-primary-site-cs-LIVER"> </a></td><td>Liver and Intrahepatic Ducts</td><td>C22 — Malignant neoplasm of liver.</td></tr><tr><td style="white-space:nowrap">PANCREAS<a name="cancer-primary-site-cs-PANCREAS"> </a></td><td>Pancreas</td><td>C25 — Malignant neoplasm of pancreas.</td></tr><tr><td style="white-space:nowrap">LUNG<a name="cancer-primary-site-cs-LUNG"> </a></td><td>Lung and Bronchus</td><td>C34 — Malignant neoplasm of bronchus and lung.</td></tr><tr><td style="white-space:nowrap">LARYNX<a name="cancer-primary-site-cs-LARYNX"> </a></td><td>Larynx</td><td>C32 — Malignant neoplasm of larynx.</td></tr><tr><td style="white-space:nowrap">NASOPHARYNX<a name="cancer-primary-site-cs-NASOPHARYNX"> </a></td><td>Nasopharynx</td><td>C11 — Malignant neoplasm of nasopharynx.</td></tr><tr><td style="white-space:nowrap">ORAL-CAVITY<a name="cancer-primary-site-cs-ORAL-CAVITY"> </a></td><td>Oral Cavity and Pharynx</td><td>C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx.</td></tr><tr><td style="white-space:nowrap">THYROID<a name="cancer-primary-site-cs-THYROID"> </a></td><td>Thyroid Gland</td><td>C73 — Malignant neoplasm of thyroid.</td></tr><tr><td style="white-space:nowrap">KIDNEY<a name="cancer-primary-site-cs-KIDNEY"> </a></td><td>Kidney</td><td>C64 — Malignant neoplasm of kidney.</td></tr><tr><td style="white-space:nowrap">BLADDER<a name="cancer-primary-site-cs-BLADDER"> </a></td><td>Urinary Bladder</td><td>C67 — Malignant neoplasm of bladder.</td></tr><tr><td style="white-space:nowrap">SKIN-MELANOMA<a name="cancer-primary-site-cs-SKIN-MELANOMA"> </a></td><td>Skin — Melanoma</td><td>C43 — Malignant melanoma of skin.</td></tr><tr><td style="white-space:nowrap">SKIN-NON-MELANOMA<a name="cancer-primary-site-cs-SKIN-NON-MELANOMA"> </a></td><td>Skin — Non-melanoma</td><td>C44 — Other malignant neoplasms of skin.</td></tr><tr><td style="white-space:nowrap">BRAIN-CNS<a name="cancer-primary-site-cs-BRAIN-CNS"> </a></td><td>Brain and CNS</td><td>C71–C72 — Malignant neoplasm of brain / CNS.</td></tr><tr><td style="white-space:nowrap">BONE<a name="cancer-primary-site-cs-BONE"> </a></td><td>Bone and Articular Cartilage</td><td>C40–C41 — Malignant neoplasm of bone.</td></tr><tr><td style="white-space:nowrap">SOFT-TISSUE<a name="cancer-primary-site-cs-SOFT-TISSUE"> </a></td><td>Soft Tissue / Sarcoma</td><td>C49 — Malignant neoplasm of connective and soft tissue.</td></tr><tr><td style="white-space:nowrap">BURKITT-LYMPHOMA<a name="cancer-primary-site-cs-BURKITT-LYMPHOMA"> </a></td><td>Burkitt Lymphoma</td><td>C83.7 — Burkitt lymphoma.</td></tr><tr><td style="white-space:nowrap">HODGKIN-LYMPHOMA<a name="cancer-primary-site-cs-HODGKIN-LYMPHOMA"> </a></td><td>Hodgkin Lymphoma</td><td>C81 — Hodgkin lymphoma.</td></tr><tr><td style="white-space:nowrap">NON-HODGKIN-LYMPHOMA<a name="cancer-primary-site-cs-NON-HODGKIN-LYMPHOMA"> </a></td><td>Non-Hodgkin Lymphoma</td><td>C82–C86 — Non-Hodgkin lymphoma.</td></tr><tr><td style="white-space:nowrap">LEUKAEMIA-ALL<a name="cancer-primary-site-cs-LEUKAEMIA-ALL"> </a></td><td>Leukaemia — ALL</td><td>C91.0 — Acute lymphoblastic leukaemia.</td></tr><tr><td style="white-space:nowrap">LEUKAEMIA-AML<a name="cancer-primary-site-cs-LEUKAEMIA-AML"> </a></td><td>Leukaemia — AML</td><td>C92.0 — Acute myeloid leukaemia.</td></tr><tr><td style="white-space:nowrap">LEUKAEMIA-CLL<a name="cancer-primary-site-cs-LEUKAEMIA-CLL"> </a></td><td>Leukaemia — CLL</td><td>C91.1 — Chronic lymphocytic leukaemia.</td></tr><tr><td style="white-space:nowrap">LEUKAEMIA-CML<a name="cancer-primary-site-cs-LEUKAEMIA-CML"> </a></td><td>Leukaemia — CML</td><td>C92.1 — Chronic myeloid leukaemia.</td></tr><tr><td style="white-space:nowrap">MULTIPLE-MYELOMA<a name="cancer-primary-site-cs-MULTIPLE-MYELOMA"> </a></td><td>Multiple Myeloma</td><td>C90.0 — Multiple myeloma.</td></tr><tr><td style="white-space:nowrap">KAPOSI-SARCOMA<a name="cancer-primary-site-cs-KAPOSI-SARCOMA"> </a></td><td>Kaposi Sarcoma</td><td>C46 — Kaposi sarcoma.</td></tr><tr><td style="white-space:nowrap">WILMS-TUMOUR<a name="cancer-primary-site-cs-WILMS-TUMOUR"> </a></td><td>Wilms Tumour (Nephroblastoma)</td><td>C64 — Malignant neoplasm of kidney (paediatric).</td></tr><tr><td style="white-space:nowrap">RETINOBLASTOMA<a name="cancer-primary-site-cs-RETINOBLASTOMA"> </a></td><td>Retinoblastoma</td><td>C69.2 — Retinoblastoma.</td></tr><tr><td style="white-space:nowrap">OTHER<a name="cancer-primary-site-cs-OTHER"> </a></td><td>Other / Not Specified</td><td>Primary site not listed or not specified.</td></tr></table></div>
</text>
<url
value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs"/>
<version value="0.1.0"/>
<name value="CancerPrimarySiteCS"/>
<title value="Kenya Cancer Primary Site Code System"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-06-04T14:49:30+00:00"/>
<publisher value="Digital Health Agency (DHA), Kenya"/>
<contact>
<name value="Digital Health Agency (DHA), Kenya"/>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
</telecom>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
</telecom>
</contact>
<contact>
<name value="Digital Health Agency Kenya – FHIR Team"/>
<telecom>
<system value="email"/>
<value value="info@dha.go.ke"/>
<use value="work"/>
</telecom>
<telecom>
<system value="url"/>
<value value="https://dha.go.ke"/>
<use value="work"/>
</telecom>
</contact>
<description
value="Codes for the anatomical primary site of a malignancy, aligned with ICD-10 topography."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="KE"/>
<display value="Kenya"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="35"/>
<concept>
<code value="BREAST"/>
<display value="Breast"/>
<definition value="C50 — Malignant neoplasm of breast."/>
</concept>
<concept>
<code value="CERVIX-UTERI"/>
<display value="Cervix Uteri"/>
<definition value="C53 — Malignant neoplasm of cervix uteri."/>
</concept>
<concept>
<code value="CORPUS-UTERI"/>
<display value="Corpus Uteri"/>
<definition value="C54 — Malignant neoplasm of corpus uteri."/>
</concept>
<concept>
<code value="OVARY"/>
<display value="Ovary"/>
<definition value="C56 — Malignant neoplasm of ovary."/>
</concept>
<concept>
<code value="PROSTATE"/>
<display value="Prostate"/>
<definition value="C61 — Malignant neoplasm of prostate."/>
</concept>
<concept>
<code value="COLON"/>
<display value="Colon"/>
<definition value="C18 — Malignant neoplasm of colon."/>
</concept>
<concept>
<code value="RECTUM"/>
<display value="Rectum"/>
<definition value="C20 — Malignant neoplasm of rectum."/>
</concept>
<concept>
<code value="OESOPHAGUS"/>
<display value="Oesophagus"/>
<definition value="C15 — Malignant neoplasm of oesophagus."/>
</concept>
<concept>
<code value="STOMACH"/>
<display value="Stomach"/>
<definition value="C16 — Malignant neoplasm of stomach."/>
</concept>
<concept>
<code value="LIVER"/>
<display value="Liver and Intrahepatic Ducts"/>
<definition value="C22 — Malignant neoplasm of liver."/>
</concept>
<concept>
<code value="PANCREAS"/>
<display value="Pancreas"/>
<definition value="C25 — Malignant neoplasm of pancreas."/>
</concept>
<concept>
<code value="LUNG"/>
<display value="Lung and Bronchus"/>
<definition value="C34 — Malignant neoplasm of bronchus and lung."/>
</concept>
<concept>
<code value="LARYNX"/>
<display value="Larynx"/>
<definition value="C32 — Malignant neoplasm of larynx."/>
</concept>
<concept>
<code value="NASOPHARYNX"/>
<display value="Nasopharynx"/>
<definition value="C11 — Malignant neoplasm of nasopharynx."/>
</concept>
<concept>
<code value="ORAL-CAVITY"/>
<display value="Oral Cavity and Pharynx"/>
<definition
value="C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx."/>
</concept>
<concept>
<code value="THYROID"/>
<display value="Thyroid Gland"/>
<definition value="C73 — Malignant neoplasm of thyroid."/>
</concept>
<concept>
<code value="KIDNEY"/>
<display value="Kidney"/>
<definition value="C64 — Malignant neoplasm of kidney."/>
</concept>
<concept>
<code value="BLADDER"/>
<display value="Urinary Bladder"/>
<definition value="C67 — Malignant neoplasm of bladder."/>
</concept>
<concept>
<code value="SKIN-MELANOMA"/>
<display value="Skin — Melanoma"/>
<definition value="C43 — Malignant melanoma of skin."/>
</concept>
<concept>
<code value="SKIN-NON-MELANOMA"/>
<display value="Skin — Non-melanoma"/>
<definition value="C44 — Other malignant neoplasms of skin."/>
</concept>
<concept>
<code value="BRAIN-CNS"/>
<display value="Brain and CNS"/>
<definition value="C71–C72 — Malignant neoplasm of brain / CNS."/>
</concept>
<concept>
<code value="BONE"/>
<display value="Bone and Articular Cartilage"/>
<definition value="C40–C41 — Malignant neoplasm of bone."/>
</concept>
<concept>
<code value="SOFT-TISSUE"/>
<display value="Soft Tissue / Sarcoma"/>
<definition
value="C49 — Malignant neoplasm of connective and soft tissue."/>
</concept>
<concept>
<code value="BURKITT-LYMPHOMA"/>
<display value="Burkitt Lymphoma"/>
<definition value="C83.7 — Burkitt lymphoma."/>
</concept>
<concept>
<code value="HODGKIN-LYMPHOMA"/>
<display value="Hodgkin Lymphoma"/>
<definition value="C81 — Hodgkin lymphoma."/>
</concept>
<concept>
<code value="NON-HODGKIN-LYMPHOMA"/>
<display value="Non-Hodgkin Lymphoma"/>
<definition value="C82–C86 — Non-Hodgkin lymphoma."/>
</concept>
<concept>
<code value="LEUKAEMIA-ALL"/>
<display value="Leukaemia — ALL"/>
<definition value="C91.0 — Acute lymphoblastic leukaemia."/>
</concept>
<concept>
<code value="LEUKAEMIA-AML"/>
<display value="Leukaemia — AML"/>
<definition value="C92.0 — Acute myeloid leukaemia."/>
</concept>
<concept>
<code value="LEUKAEMIA-CLL"/>
<display value="Leukaemia — CLL"/>
<definition value="C91.1 — Chronic lymphocytic leukaemia."/>
</concept>
<concept>
<code value="LEUKAEMIA-CML"/>
<display value="Leukaemia — CML"/>
<definition value="C92.1 — Chronic myeloid leukaemia."/>
</concept>
<concept>
<code value="MULTIPLE-MYELOMA"/>
<display value="Multiple Myeloma"/>
<definition value="C90.0 — Multiple myeloma."/>
</concept>
<concept>
<code value="KAPOSI-SARCOMA"/>
<display value="Kaposi Sarcoma"/>
<definition value="C46 — Kaposi sarcoma."/>
</concept>
<concept>
<code value="WILMS-TUMOUR"/>
<display value="Wilms Tumour (Nephroblastoma)"/>
<definition value="C64 — Malignant neoplasm of kidney (paediatric)."/>
</concept>
<concept>
<code value="RETINOBLASTOMA"/>
<display value="Retinoblastoma"/>
<definition value="C69.2 — Retinoblastoma."/>
</concept>
<concept>
<code value="OTHER"/>
<display value="Other / Not Specified"/>
<definition value="Primary site not listed or not specified."/>
</concept>
</CodeSystem>